These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
385 related items for PubMed ID: 17388815
1. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats. Reyna-Neyra A, Sarkar G, Etgen AM. J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815 [Abstract] [Full Text] [Related]
2. Estradiol and progesterone modulate the nitric oxide/cyclic gmp pathway in the hypothalamus of female rats and in GT1-1 cells. Chu HP, Sarkar G, Etgen AM. Endocrine; 2004 Jul; 24(2):177-84. PubMed ID: 15347845 [Abstract] [Full Text] [Related]
3. A potential role of cyclic GMP in the regulation of lordosis behavior of female rats. Chu HP, Etgen AM. Horm Behav; 1997 Oct; 32(2):125-32. PubMed ID: 9367720 [Abstract] [Full Text] [Related]
4. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation. Johns RA, Tichotsky A, Muro M, Spaeth JP, Le Cras TD, Rengasamy A. Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063 [Abstract] [Full Text] [Related]
5. Localization and characterization of cGMP-immunoreactive structures in rat brain slices after NO-dependent and NO-independent stimulation of soluble guanylyl cyclase. van Staveren WC, Markerink-van Ittersum M, Steinbusch HW, Behrends S, de Vente J. Brain Res; 2005 Mar 02; 1036(1-2):77-89. PubMed ID: 15725404 [Abstract] [Full Text] [Related]
6. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole]. Teixeira CE, Priviero FB, Webb RC. J Pharmacol Exp Ther; 2006 Apr 02; 317(1):258-66. PubMed ID: 16352702 [Abstract] [Full Text] [Related]
7. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats. Chalimoniuk M, Chrapusta SJ, Lukačova N, Langfort J. Brain Res; 2015 Aug 27; 1618():29-40. PubMed ID: 26006108 [Abstract] [Full Text] [Related]
8. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Wohlfart P, Malinski T, Ruetten H, Schindler U, Linz W, Schoenafinger K, Strobel H, Wiemer G. Br J Pharmacol; 1999 Nov 27; 128(6):1316-22. PubMed ID: 10578147 [Abstract] [Full Text] [Related]
9. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells. Kostic TS, Andric SA, Stojilkovic SS. Mol Endocrinol; 2004 Feb 27; 18(2):458-70. PubMed ID: 14630997 [Abstract] [Full Text] [Related]
11. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra. Toque HA, Antunes E, Teixeira CE, De Nucci G. Urology; 2008 Sep 27; 72(3):711-5. PubMed ID: 18359064 [Abstract] [Full Text] [Related]
12. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R. Br J Pharmacol; 1997 Feb 27; 120(4):681-9. PubMed ID: 9051308 [Abstract] [Full Text] [Related]
13. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size. Bice JS, Keim Y, Stasch JP, Baxter GF. Cardiovasc Res; 2014 Feb 01; 101(2):220-8. PubMed ID: 24259501 [Abstract] [Full Text] [Related]
14. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum. Hernández-Viadel M, Castoldi AF, Coccini T, Manzo L, Erceg S, Felipo V. J Neurochem; 2004 Jun 01; 89(5):1157-65. PubMed ID: 15147508 [Abstract] [Full Text] [Related]
15. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Wegener JW, Gath I, Förstermann U, Nawrath H. Br J Pharmacol; 1997 Dec 01; 122(7):1523-9. PubMed ID: 9421305 [Abstract] [Full Text] [Related]
16. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance]. Severina IS. Biomed Khim; 2007 Dec 01; 53(4):385-99. PubMed ID: 18035720 [Abstract] [Full Text] [Related]
17. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats. Schäfer A, Flierl U, Kobsar A, Eigenthaler M, Ertl G, Bauersachs J. Arterioscler Thromb Vasc Biol; 2006 Dec 01; 26(12):2813-8. PubMed ID: 17023677 [Abstract] [Full Text] [Related]
18. Regulation of nitric oxide-sensitive guanylyl cyclase. Friebe A, Koesling D. Circ Res; 2003 Jul 25; 93(2):96-105. PubMed ID: 12881475 [Abstract] [Full Text] [Related]
19. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells. Borges de Oliveira-Junior E, Thomazzi SM, Rehder J, Antunes E, Condino-Neto A. Eur J Pharmacol; 2007 Jul 12; 567(1-2):43-9. PubMed ID: 17499238 [Abstract] [Full Text] [Related]
20. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator. Nakane M, Kolasa T, Chang R, Miller LN, Moreland RB, Brioni JD. J Pharmacol Sci; 2006 Oct 12; 102(2):231-8. PubMed ID: 17050951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]